Advertisement
News
Subscribe to MDT Magazine News

Control Risks Forecasts New Reality for Business in 2011 Brought by Emerging Markets, Legislation

December 15, 2010 7:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- Control Risks , one of the world's leading business risk consultancies, today launches RiskMap 2011 – its annual review and forecast of business risk for the year ahead, including regional outlooks, and a rating of political and...

TOPICS:

RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group

December 15, 2010 7:34 am | by Bio-Medicine.Org | Comments

LAKE FOREST, Ill., Dec. 15, 2010 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Clinical...

TOPICS:

Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design

December 15, 2010 7:34 am | by Bio-Medicine.Org | Comments

RALEIGH, N.C., Dec. 15, 2010 /- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, has appointed Nathan Pienkowski, Ph.D., as Instructional Design Director.  In this role,...

TOPICS:
Advertisement

Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee

December 15, 2010 7:34 am | by Bio-Medicine.Org | Comments

NEW BRUNSWICK, N.J., Dec. 15, 2010 /- Johnson & Johnson (NYSE: JNJ ) today announced that Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics (MD&D) and Sheri McCoy, currently Worldwide Chairman, Pharmaceuticals, have been appointed Vice Chairmen of the...

TOPICS:

NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance

December 15, 2010 7:33 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, Dec. 15, 2010 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced that NASDAQ has given the company until June 13, 2011, to comply with its $1 per share minimum bid rule. "Given the challenges of the general economy, we welcome the grant by NASDAQ of an additional...

TOPICS:

New Study Classifies and Analyzes Protein-Protein Interfaces

December 15, 2010 7:33 am | by Georgia Tech Institute of Technology | Comments

A new study published this week suggests that there may be roughly a thousand structurally-distinct protein-protein interfaces -- and that their structures depend largely on the simple physics of the proteins.

TOPICS:

Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center

December 15, 2010 7:32 am | by EurekAlert | Comments

(Virginia Commonwealth University) Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the...

TOPICS:

Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor

December 15, 2010 7:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Dec. 15, 2010 /- Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin.  Autotaxin is an enzyme upstream from LPA receptors and has been...

TOPICS:
Advertisement

Accuray gets approval for new CyberKnife component

December 15, 2010 5:45 am | by The Associated Press | Comments

Accuray Inc. said Wednesday it received Food and Drug Administration marketing clearance for a component of its CyberKnife radiation therapy device.The company said the component is used in the treatment of lung cancer, one of the conditions CyberKnife VSI systems are approved to treat.Shares...

STATS ChipPAC and Intersil qualify and ramp copper wire interconnect for high-end analog and mixed-signal devices

December 15, 2010 5:33 am | by I-Micronews | Comments

STATS ChipPAC Ltd. (?STATS ChipPAC? ? SGX-ST: STATSChP), a leading semiconductor test and advanced packaging service provider, and Intersil Corporation (NASDAQ Global Select: ISIL) today announced they have qualified copper wire interconnect on a number of high-end analog and mixed-signal...

Event: MAM2011 - Equipment for Microproducts

December 15, 2010 5:33 am | by I-Micronews | Comments

On January 16-18, 2011, Villars-sur-Ollon, Switzerland. Following in the success of the first edition, The Micronarc Alpine Meeting 2011 will continue its focus on equipment for manufacturing microproducts.

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Public Health ...

December 15, 2010 5:33 am | by U.S. Food & Drug Administration | Comments

The FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Sage Products and 3M Infection Prevention Announce Agreement

December 15, 2010 5:32 am | by Bio-Medicine.Org | Comments

CARY, Ill. and ST. PAUL, Minn., Dec. 15, 2010 /- Sage Products, Inc. and the 3M Infection Prevention Division have entered into an agreement in which Sage Products will purchase pre-filled, single dose bottles of 3M™ Peridex™ Oral Rinse for its Q-Care® Rx systems,...

TOPICS:

Accuray Receives FDA Clearance for the CyberKnife® System's Lung Optimized Treatment

December 15, 2010 5:31 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Dec. 15, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the...

TOPICS:

Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors

December 15, 2010 4:32 am | by Bio-Medicine.Org | Comments

EMERYVILLE, Calif., Dec. 15, 2010 /- Bionovo, Inc. (Nasdaq: BNVI ) today announced the publication of a study entitled "CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation" in the journal Cell Cycle . The study describes the critical linkage between the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading